About ASPERA BIOMEDICINES, INC.
Aspera Biomedicines is a space-accelerated biotechnology company developing first-in-class therapies that target cancer stem cells to end cancer relapse and extend human healthspan. The company leverages NASA-funded low-Earth orbit research to advance its pipeline of cancer treatments.
Space-accelerated cancer stem cell researchDevelopment of first-in-class ADAR1 inhibitorsLow-Earth orbit experiments to accelerate drug discoveryTargeting of over 20 cancersProprietary nanobioreactor platforms for microgravity research
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| RESEARCH AND DEVELOPMENT FOR IN-SPACE PRODUCTION CONCEPTS OF NANOBIOREACTOR MODELS. THIS WAS AWARDED OFF OF TH | National Aeronautics and Space Administration | $3.2M |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ASPERA BIOMEDICINES, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.